Earnings Feed
Start Free
|4Mar 7, 4:45 PM ET

Bahrt Kenneth 4

4 · SAVIENT PHARMACEUTICALS INC · Filed Mar 7, 2013

Insider Transaction Report

Form 4
Period: 2013-03-05
SAVIENT PHARMACEUTICALS INCSVNT
Bahrt Kenneth
SVP, Chief Medical Officer
Transactions
  • Award

    Option to Purchase Common Stock

    2013-03-05+110,000→ 110,000 total
    Exercise: $0.94Exp: 2023-03-05→ Common Stock (110,000 underlying)
  • Award

    Option to Purchase Common Stock

    2013-03-05+90,000→ 90,000 total
    Exercise: $2.26Exp: 2022-02-01→ Common Stock (90,000 underlying)
  • Award

    Option to Purchase Common Stock

    2013-03-05+50,000→ 50,000 total
    Exercise: $7.00Exp: 2021-07-31→ Common Stock (50,000 underlying)
Holdings

  • Common Stock

    179,461
Footnotes (3)
  • [F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
  • [F2]These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012.
  • [F3]These options reflect the vesting of performance options that were granted to the reporting person effective July 31, 2011.

Documents

1 file
  • 4
    rrd373115.xmlPrimary

    BAHRT FORM 4